Tyler Seibert is an Oncology physician affiliated with University of California San Diego. OpenAlex indexes 260 publications with 3,708 citations (h-index 32); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 W Arbor Dr
San Diego, CA 92103
Telephone
858-822-6040Registry record last updated 12 Jun 2018.
Clinical trials
- Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer
Sponsor: University of California, San Diego
- Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate Cancer
Sponsor: University of California, San Diego
- BladdEr Full OR Empty for Pelvic Radiation Therapy
Sponsor: University of California, San Diego
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Blue Earth DiagnosticsProgram year20256 payments
- GE HEALTHCAREProgram year20255 payments
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
87.3%alpha-Adrenergic Blocker68.6%Tamsulosin Hcl100%Part D≥22 patientsCholinergic Muscarinic Antagonist18.6%Oxybutynin Chloride Er100%Part D≥11 patientsCancer & immunology
12.7%Androgen Receptor Inhibitor12.7%Bicalutamide100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2019–2022 per NIH RePORTER. The latest:
- Improving assessment of prostate cancer bone metastases using advanced diffusion imaging
University of California, San Diego
FY2022$201,280K08EB026503 - Improving assessment of prostate cancer bone metastases using advanced diffusion imaging
University of California, San Diego
FY2021$201,280K08EB026503 - Improving assessment of prostate cancer bone metastases using advanced diffusion imaging
University of California, San Diego
FY2020$201,280K08EB026503
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review
World Journal of Urology
2024 - NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023
Journal of the National Comprehensive Cancer Network
2023 - ReIGNITE Radiation Therapy Boost: A Prospective, International Study of Radiation Oncologists’ Accuracy in Contouring Prostate Tumors for Focal Radiation Therapy Boost on Conventional Magnetic Resonance Imaging Alone or With Assistance of Restriction Spectrum Imaging
International Journal of Radiation Oncology*Biology*Physics
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Jay Giedd, MD
University of California San Diego
Robert Weinreb, MD
University of California San Diego
Dilip Jeste, MD
University of California San Diego
Igor Grant, MD
University of California San Diego
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”